- Home
- SPHR vs IMNM Comparison
SPHR vs IMNM Comparison
Compare SPHR & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPHR | IMNM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.8B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPHR | IMNM |
|---|---|---|
| Price | $117.01 | $21.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $96.36 | $32.80 |
| AVG Volume (30 Days) | 747.3K | ★ 956.4K |
| Earning Date | 05-14-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.03 | 51.40 |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,220,045,000.00 | $6,941,000.00 |
| Revenue This Year | $12.37 | $18.41 |
| Revenue Next Year | N/A | $863.23 |
| P/E Ratio | $150.84 | ★ N/A |
| Revenue Growth | ★ 18.81 | N/A |
| 52 Week Low | $23.89 | $5.15 |
| 52 Week High | $120.27 | $27.65 |
Technical Indicators
Market Signals| Indicator | SPHR | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 59.04 | 45.84 |
| Support Level | $109.61 | $18.98 |
| Resistance Level | $119.20 | $22.57 |
| Average True Range (ATR) | 4.28 | 1.04 |
| MACD | -0.46 | -0.09 |
| Stochastic Oscillator | 57.08 | 56.16 |
Price Performance
Historical ComparisonAbout SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.